MRC1 and classic Hodgkin lymphoma: The microarray analysis of cHL tissues revealed an high expression of CD206 in patients with stage IV disease, indicating that the presence of M2-TAM with high CD206 expression and likely with expected increased matrix-remodeling capacity, could characterize advanced stages of cHL [18].